REQUEST A DEMO
Total
USD $0.00
Search more companies

+Pharma Ceska Republika S.R.O. (Czech Republic)

Main Activities: Research and Development in Nanotechnology | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Building Equipment Contractors | Surgical and Medical Instrument Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | All Other Support Activities for Transportation | Testing Laboratories
Full name: +Pharma Ceska Republika S.R.O. Profile Updated: December 25, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

+Pharma Ceska Republika S.R.O. is based in Czech Republic. The head office is in Prague. The enterprise operates in the Research and Development in Nanotechnology industry. The company was established on October 06, 2008. It currently has a total number of 25 - 49 (2023) employees. From the latest financial highlights, +Pharma Ceska Republika S.R.O. reported a net sales revenue increase of 14.1% in 2024. Its’ total assets recorded a negative growth of 2.14%. The net profit margin of +Pharma Ceska Republika S.R.O. increased by 0.3% in 2024.

Headquarters
U Pergamenky 1522/2
Prague; The City of Prague; Postal Code: 17000

Contact Details: Purchase the +Pharma Ceska Republika S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the +Pharma Ceska Republika S.R.O. report to view the information.
Registered Capital:
Purchase the +Pharma Ceska Republika S.R.O. report to view the information.
Financial Auditors:
Purchase the +Pharma Ceska Republika S.R.O. report to view the information.
Incorporation Date:
October 06, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after +Pharma Ceska Republika S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
14.1%
Total operating revenue
14.1%
Operating profit (EBIT)
11.17%
EBITDA
11.07%
Net Profit (Loss) for the Period
20.54%
Total Assets
-2.14%
Total Equity
20.89%
Operating Profit Margin (ROS)
-0.49%
Net Profit Margin
0.3%
Return on Equity (ROE)
-9.08%
Quick Ratio
0.1%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?